American society of transplantation recommendations for screening, monitoring and reporting of infectious complications in immunosuppression trials in recipients of organ transplantation

American Journal of Transplantation

Volumn 6, Issue 2, 2006, Pages 262-274

  Humar, A ^a   Michaels, M ^a  

^a NONE

Author keywords

Clinical trials; Immunosuppression; Infectious diseases

Indexed keywords

IMMUNOSUPPRESSIVE AGENT;

ABDOMINAL INFECTION; ASPERGILLUS; BACTEREMIA; BACTERIAL PNEUMONIA; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL TRIAL; CYSTITIS; CYTOMEGALOVIRUS; DISEASE ASSOCIATION; EPSTEIN BARR VIRUS; EVALUATION; GASTROINTESTINAL DISEASE; HEPATITIS; HEPATITIS C; HEPATITIS C VIRUS; HERPES SIMPLEX VIRUS; HUMAN; HUMAN HERPESVIRUS 8; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; LABORATORY TEST; MORBIDITY; MORTALITY; MYCOSIS; MYOCARDITIS; NEPHRITIS; ORGAN TRANSPLANTATION; PANCREATITIS; PNEUMONIA; PRIORITY JOURNAL; RETINITIS; REVIEW; RISK ASSESSMENT; URINARY TRACT INFECTION; VARICELLA ZOSTER VIRUS; VIRUS INFECTION;

CLINICAL TRIALS; HUMANS; IMMUNOSUPPRESSION; INFECTION; MONITORING, PHYSIOLOGIC; ORGAN TRANSPLANTATION; POSTOPERATIVE COMPLICATIONS; QUALITY ASSURANCE, HEALTH CARE; SOCIETIES, MEDICAL; UNITED STATES;

EID: 33644887736     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2005.01207.x     Document Type: Review

References (58)

1. Cytomegalovirus Guidelines for the prevention and management of infectious complications of solid organ transplantation Am J Transplant 2004 4 Suppl. 10 51 58
2. Preiksaitis JK Brennan DC Fishman J Allen U Canadian society of transplantation consensus workshop on cytomegalovirus management in solid organ transplantation final report Am J Transplant 2005 5 218 227
3. Paya CV Razonable RR Cytomegalovirus infection after solid organ transplantation In Bowden RA Ljungman P Paya CV eds Transplant Infections 2nd Edn Philadelphia PA USA Lippincott, Williams & Wilkins 2003 298 325
4. Boeckh M Boivin G Quantitation of cytomegalovirus: methodologic aspects and clinical applications Clin Microbiol Rev 1998 11 533 554
5. Caliendo AM Schuurman R Yen-Lieberman B et al Comparison of quantitative and qualitative PCR assays for cytomegalovirus DNA in plasma J Clin Microbiol 2001 39 1334 1338
6. Ljungman P Stanley PA Workshop on cytomegalovirus disease; definitions, clinical severity scores and new syndromes Scand J Infect Dis 1995 99 Suppl. 87 89
7. Limaye AP Ganciclovir-resistant cytomegalovirus in organ transplant recipients Clin Infect Dis 2002 35 866 872
8. Epstein-Barr virus and lymphoproliferative disorders after transplantation Guidelines for the prevention and management of infectious complications of solid organ transplantation Am J Transplant 2004 4 Suppl. 10 59 61
9. Harris NL Ferry JA Swerdlow SH Posttransplant lymphoproliferative disorders: summary of Society for Hematopathology Workshop Semin Diagn Pathol 1997 14 8 14
10. Paya CV Fung JJ Nalesnik MA et al Epstein-Barr virus-induced posttransplant lymphoproliferative disorders Transplantation 1999 68 1517 1525
11. Haque T Thomas JA Falk KI et al Transmission of donor Epstein-Barr virus (EBV) in transplanted organs causes lymphoproliferative disease in EBV-seronegative recipients J Gen Virol 1996 77 1169 1172
12. Swinnen LJ Costanzo-Nordin MR Fisher SG et al Increased incidence of lymphoproliferative disorder after immunosuppression with the monoclonal antibody OKT3 in cardiac-transplant recipients N Engl J Med 1990 323 1723 1728
13. Guthery SL Heubi JE Bucuvalas JC et al Determination of risk factors for Epstein-Barr virus-associated posttransplant lymphoproliferative disorder in pediatric liver transplant recipients using objective case ascertainment Transplantation 2003 75 987 993
14. Cherikh WS Kauffman HM McBride MA Maghirang J Swinnen LJ Hanto DW Association of the type of induction immunosuppression with posttransplant lymphoproliferative disorder, graft survival, and patient survival after primary kidney transplantation Transplantation 2003 76 1289 1293
15. Preiksaitis JK Keay S Diagnosis and management of posttransplant lymphoproliferative disorder in solid-organ transplant recipients Clin Infect Dis 2001 33 S38 S46
16. Kenagy DN Schlesinger Y Wesk K Ritter JH Epstein-Barr virus DNA in peripheral blood leukocytes of patients with posttransplant lymphoproliferative disease Transplantation 1995 60 547 554
17. Savoie A Perpete C Carpentier L Jonas J Alfieri C Direct correlation between the load of Epstein-Barr virus-infected lymphocytes in the peripheral blood of pediatric transplant recipients and risk of lymphoproliferative disease Blood 1994 83 2715 2722
18. Allen U Hebert D Petric M et al Utility of semiquantitative polymerase chain reaction for Epstein-Barr virus to measure virus load in pediatric organ transplant recipients with and without posttransplant lymphoproliferative disease Clin Infect Dis 2001 33 145 50
19. Rowe DT Qu L Reyes J et al Use of quantitative competitive PCR to measure Epstein-Barr virus genome load in peripheral blood of pediatric transplant recipients with lymphoproliferatice disorders J Clin Microbiol 1997 35 1612
20. Other herpesviruses Guidelines for the prevention and management of infectious complications of solid organ transplantation Am J Transplant 2004 4 Suppl. 10 66 71
21. Gnann JW Jr. Herpes simplex and varicella zoster virus infection after hemopoietic stem cell or solid organ transplantation In Bowden RA Ljungman P Paya CV eds Transplant Infections 2nd Edn Philadelphia PA USA Lippincott, Williams & Wilkins 2003 350 366
22. Singh N Dummer JS Kusne S et al Infections with cytomegalovirus and other herpesviruses in 121 liver transplant recipients: transmission by donated organ and the effect of OKT3 antibodies J Infect Dis 1988 158 124 131
23. Smyth RL Higenbottam TW Scott JP et al Herpes simplex virus infection in heart-lung transplant recipients Transplantation 1990 49 735 739
24. Antman K Chang Y Kaposi's sarcoma N Engl J Med 2000 342 1027 1038
25. Allen U Human herpesvirus type 8 infections among solid organ transplant recipients Pediatr Transplant 2002 6 187 192
26. Ljungman P Beta-herpesvirus challenges in the transplant recipient J Infect Dis 2002 186 Suppl. 1 S99 S109
27. Dockrell DH Paya CV Human herpesvirus-6 and -7 in transplantation Rev Med Virol 2001 11 23 36
28. Singh N Carrigan DR Human herpesvirus-6 in transplantation: an emerging pathogen Ann Intern Medical 1996 124 1065 1071
29. Hirsch HH Steiger J Polyomavirus BK Lancet Infect Dis 2003 3 611 623
30. Kazory A Ducloux D Renal transplantation and polyomavirus infection: recent clinical facts and controversies Transpl Infect Dis 2003 5 65 71
31. Randhawa PS Demetris AJ Nephropathy due to polyomavirus type BK N Engl J Med 2000 342 1361 1363
32. Vats A BK virus-associated transplant nephropathy: need for increased awareness in children Pediatr Transplant 2004 8 421 425
33. Haririan A Ramos ER Drachenberg CB Weir MR Klassen DK Polyomavirus nephropathy in native kidneys of a solitary pancreas transplant recipient Transplantation 2002 73 1350 1353
34. Hirsch HH Brennan DC Drachenberg CB et al Polyomavirus-associated nephropathy in renal transplantation: interdisciplinary analyses and recommendations Transplantation 2005 79 1277 1286
35. Hirsch HH Knowles W Dickenmann M et al Prospective study of polyomavirus type BK replication and nephropathy in renal-transplant recipients N Engl J Med 2002 347 488 496
36. Nickeleit V Klimkait T Binet IF et al Testing for polyomavirus type BK DNA in plasma to identify renal-allograft recipients with viral nephropathy N Engl J Med 2000 342 1309 1315
37. Gane EJ Portmann BC Naoumov NV et al Long-term outcome of hepatitis C infection after liver transplantation N Engl J Med 1996 334 815 820
38. Testa G Crippin JS Netto GJ et al Liver transplantation for hepatitis C: recurrence and disease progression in 330 patients Liver Transpl 2000 6 553 561
39. Berenguer M Ferrell L Watson J et al HCV-related fibrosis progression following orthotopic liver transplantation: increase in recent years J Hepatol 2000 32 673 684
40. Papatheodoridis GV, Davies S Dhillon AP et al The role of different immunosuppression in the long-term histological outcome of HCV reinfection after liver transplantation for HCV cirrhosis Transplantation 2001 72 412 418
41. Martin P Busuttil RW Goldstein RM et al Impact of tacrolimus vs cyclosporine in hepatitis C virus infected liver transplant recipients on recurrent hepatitis: a prospective, randomized trial Liver Transpl 2004 10 1258 1262
42. Pessoa MG Wright TL Hepatitis C infection in transplantation Clinics in Liver Disease 1997 1 663 690
43. Viral hepatitis guidelines in hemodialysis and transplantation Guidelines for the prevention and management of infectious complications of solid organ transplantation Am J Transplant 2004 4 Suppl. 10 72 82
44. Bedossa P Poynard T An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group Hepatology 1996 24 289 293
45. Kanj SS Welty-Wolf K Madden J et al Fungal infections in lung and heart-lung transplant recipients: report of 9 cases and review of the literature Medicine 1996 75 142 156
46. Paterson DL Singh N Invasive aspergillosis in transplant recipients Medicine 1999 78 123 138
47. Paya CV Fungal infections in solid-organ transplantation Clin Infect Dis 1993 16 677 688
48. Fungal Infections Guidelines for the prevention and management of infectious complications of solid organ transplantation Am J Transplant 2004 4 Suppl. 10 110 134
49. Husain S Tollemar J Dominguez EA et al Changes in the spectrum and risk factors for invasive candidiasis in liver transplant recipients: prospective, multicenter, case-controlled study Transplantation 2003 75 2023 2029
50. Ascioglu S Rex JH Bennett JE etal Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus Clin Infect Dis 2002 34 7 14
51. Singh N Husain S Aspergillus infections after lung transplantation: clinical differences in type of transplant and implications for management J Heart Lung Transplant 2003 21 258 266
52. Munoz P Alcala L Sanchez Conde M et al The isolation of Aspergillus fumigatus from respiratory tract specimens in heart transplant recipients is highly predictive of invasive aspergillosis Transplantation 2003 75 326 329
53. Fortun J Martin-Davila P Alvarez ME et al The Ramon y Cajal Hospital's liver Transplant Group Aspergillus antigenemia sandwich-enzyme immunoassay test as a serodiagnostic method for invasive aspergillosis in liver transplant recipients Transplantation 2001 71 145 149
54. ® Aspergillus enzyme immunoassay for the diagnosis of invasive aspergillosis in liver transplant recipients J Clin Microbiol 2004 42 435 438
55. Husain S Kwak EJ Obman A et al Propsective assessment of platelia™ Aspergillus galactomannan antigen for the diagnosis of invasive aspergillosis in lung transplant recipients Am J Transplant 2004 4 796 802
56. Horan TC Gaynes RP Surveillance of nosocomial infections In Mayhall CG ed Hospital Epidemiology and Infection Control 3rd Edn Philadelphia PA USA Lippincott Williams & Wilkins 2004 1659 1702 Also available at
57. http://www.hhs.gov/ohrp/humansubjects/guidance/reposit.htm.
58. http://www.hhs.gov/ohrp/humansubjects/guidance/45cfr46.htm#46.116.